Among neuroendocrine tumors, plasma progastrin-releasing peptide (ProGRP) (upper limit of the normal range: 81 pg/mL) is routinely used as a specific tumor marker for small-cell lung cancer in clinical practice [3]. This evidence concerns the gene GRP and neuroendocrine neoplasm.